Clinical trials
Observational Head and Neck Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Unknown status | 4 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 4 |
| University Medical Center Groningen | 4 |
| Maastricht Radiation Oncology | 3 |
| The Netherlands Cancer Institute | 2 |
| Azienda Ospedaliero-Universitaria di Parma | 1 |
| Leiden University Medical Center | 1 |
| Maastricht University Medical Center | 1 |
| UMC Utrecht | 1 |
| University of Alberta | 1 |
| XEOS Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 19 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Breast Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Hypoxia | 2 |
| Neoplasms | 2 |
| Oropharyngeal Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Squamous Cell | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.